Picture of ExpreS2ion Biotech Holding AB logo

EXPRS2 — ExpreS2ion Biotech Holding AB News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Brief: Expres2ion Q3 Loss After Financial Items Widens To SEK 31.8 Mln

Nov 17 (Reuters) - ExpreS2ion Biotech Holding AB
 EXPRS2.ST :
    * EXPRES2ION ANNOUNCES FINANCIAL RESULTS FOR THE THIRD
QUARTER
2022
    * Q3 OPERATING INCOME AMOUNTED TO 909 (2,576) KSEK.
    * Q3 LOSS AFTER FINANCIAL ITEMS AMOUNTED TO -31,810
(-10,308)
KSEK.

Source text for Eikon:  ID:nWkr8gKNjW 
Further company coverage:  EXPRS2.ST 
 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))

Recent news on ExpreS2ion Biotech Holding AB

See all news